Thomas McFall
8PUBLICATIONS
72CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 20, 2026
KRASG12R-Mutant Pancreatic Cancer Features Limited ERK/MAPK Transcriptional Activity and a Distinctive Tumor Microenvironment.Rachel A Burge, Ozgun Le Roux, Olesja Popow
|Oct 24, 2025
Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma.Mandana Kamgar, G Aaron Hobbes, Raven Davidson
|Sep 15, 2025
Pancreatic Cells Are Resistant to KRASQ61L Expression due to Hyperactive ERK/MAPK Signaling and Apoptosis Induction.Rachel A Burge, Lucas Bialousow, Thomas McFall
|Nov 23, 2022
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP.Thomas McFall, Michael Trogdon, Anita C Guizar
|Mar 12, 2020
A mechanism for the response of KRASG13D expressing colorectal cancers to EGFR inhibitors.Thomas McFall, Edward Cooper Stites
Pageof 2
Frequent Collaborators
4 joint publications
G Aaron Hobbs
3 joint publications
Edward Cooper Stites
3 joint publications
John F Langenheim
3 joint publications
Rachel A Burge
2 joint publications
Raven Davidson
2 joint publications
Daniel Dorbin
2 joint publications
Lucas Bialousow
2 joint publications
Mandana Kamgar
2 joint publications
Grayson Johnson
2 joint publications
Silvia G Vaena